Business

July 5, 2014

JCB exec says company will stay put even with European acquisition

At the beginning of the year, a European concern was quietly closing on its acquisition of Wichita’s JCB Laboratories, a high-tech sterile pharmaceutical compounding company that its top executive said has seen significant revenue growth over the past two years.

Related content

Comments

Videos

Editor's Choice Videos